TY - JOUR
T1 - Contribution of phosphates and adenine to the potency of adenophostins at the IP 3 receptor
T2 - synthesis of all possible bisphosphates of adenophostin A
AU - Sureshan, Kana M.
AU - Riley, Andrew M.
AU - Thomas, Mark P.
AU - Tovey, Stephen C.
AU - Taylor, Colin W.
AU - Potter, Barry V. L.
PY - 2012
Y1 - 2012
N2 - Although adenophostin A (AdA), the most potent agonist of d-myo-inositol 1,4,5-trisphosphate receptors (IP 3R), is thought to mimic IP 3, the relative roles of the different phosphate groups and the adenosine motif have not been established. We synthesized all three possible bisphosphate analogues of AdA and glucose 3,4-bisphosphate (7, AdA lacking the 2′-AMP). 2′-Dephospho-AdA (6) was prepared via a novel regioselective dephosphorylation strategy. Assessment of the abilities of these bisphosphates to stimulate intracellular Ca 2+ release using recombinant rat type 1 IP 3R (IP 3R1) revealed that 6, a mimic of Ins(4,5)P 2, is only 4-fold less potent than IP 3, while 7 is some 400-fold weaker and even 3′3-dephospho-AdA (5) is measurably active, despite missing one of the vicinal bisphosphate groups normally thought to be crucial for IP 3-like activity. Compound 6 is the most potent bisphosphate yet discovered with activity at IP 3R. Thus, adenosine has a direct role independent of the 2′-phosphate group in contributing toward the potency of adenophostins, the vicinal bisphosphate motif is not essential for activity at the IP 3R, as always thought, and it is possible to design potent agonists with just two of the three phosphates. A model with a possible adenine-R504 interaction supports the activity of 5 and 6 and also allows a reappraisal of the unexpected activity previously reported for the AdA regioisomer 2′3-phospho-3′3- dephospho-AdA 40.
AB - Although adenophostin A (AdA), the most potent agonist of d-myo-inositol 1,4,5-trisphosphate receptors (IP 3R), is thought to mimic IP 3, the relative roles of the different phosphate groups and the adenosine motif have not been established. We synthesized all three possible bisphosphate analogues of AdA and glucose 3,4-bisphosphate (7, AdA lacking the 2′-AMP). 2′-Dephospho-AdA (6) was prepared via a novel regioselective dephosphorylation strategy. Assessment of the abilities of these bisphosphates to stimulate intracellular Ca 2+ release using recombinant rat type 1 IP 3R (IP 3R1) revealed that 6, a mimic of Ins(4,5)P 2, is only 4-fold less potent than IP 3, while 7 is some 400-fold weaker and even 3′3-dephospho-AdA (5) is measurably active, despite missing one of the vicinal bisphosphate groups normally thought to be crucial for IP 3-like activity. Compound 6 is the most potent bisphosphate yet discovered with activity at IP 3R. Thus, adenosine has a direct role independent of the 2′-phosphate group in contributing toward the potency of adenophostins, the vicinal bisphosphate motif is not essential for activity at the IP 3R, as always thought, and it is possible to design potent agonists with just two of the three phosphates. A model with a possible adenine-R504 interaction supports the activity of 5 and 6 and also allows a reappraisal of the unexpected activity previously reported for the AdA regioisomer 2′3-phospho-3′3- dephospho-AdA 40.
UR - http://www.scopus.com/inward/record.url?scp=84863401968&partnerID=8YFLogxK
UR - http://dx.doi.org/10.1021/jm201571p
U2 - 10.1021/jm201571p
DO - 10.1021/jm201571p
M3 - Article
SN - 0022-2623
VL - 55
SP - 1706
EP - 1720
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 4
ER -